Archives

Loading Events

Autosomal Dominant Polycystic Kidney Disease (ADPKD): Screening & Diagnosis

Autosomal Dominant Polycystic Kidney Disease (ADPKD): Screening & Diagnosis

This presentation discusses the key screening tools and diagnostic algorithms associated with autosomal dominant polycystic kidney disease (ADPKD), including risk assessment tools to assess for rapid progression.

Location

The Butcher’s Son

1556 Laskin Road #134
Virginia Beach, VA 23451 United States
+ Google Map
7575007550 View Venue Website

Featuring

Kimberly Means

Kimberly Means, PharmD, BCCCP, BSN, RN

Medical Science Liaison

Otsuka Pharmaceutical Development & Commercialization, Inc.*

Kimberly Means, PharmD, BCCCP, BSN, RN, is a Medical Science Liaison at Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC).  Dr Means earned her B.S. in Nursing (BSN) and her Doctor of Pharmacy (PharmD) from Virginia Commonwealth University (VCU) in Richmond, Virginia.  She completed a PGY-1 Pharmacy Practice Residency and a PGY-2 Critical Care Residency at VCU Health in Richmond, Virginia.  Prior to joining Otsuka, she worked as a critical care nurse at VCU Health, a Critical Care Clinical Pharmacist at Henrico Doctors’ Hospital, and a Clinical Pharmacist in Surgical Services at VCU Health.  During her time as a Clinical Assistant Professor at the VCU School of Pharmacy and VCU Health she served as a preceptor for pharmacy students and pharmacy residents.  Dr Means is a Board Certified Critical Care Pharmacotherapy Specialist (BCCCP).

Michael Filsinger

Michael Filsinger, MPA, PA-C

Nephrology Medical Science Liaison

Otsuka Pharmaceutical Development & Commercialization, Inc.*

Michael Filsinger, MPA, PA-C is a Medical Science Liaison at Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Michael earned his Bachelor of Health Care Sciences as well as Master of Physician Assistant at Duquesne University in Pittsburgh, PA. Following his graduate training, Michael went on to complete a Pediatric Surgery Residency at Children’s National Medical Center in Washington, DC Prior to joining Otsuka, Michael spent the last 15 years working in solid organ transplant in Charlotte, NC where he developed a passion for improving the care of patients with renal disease and ESKD.

Dr Kimberly Means and Michael Filsinger are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC).

Registration

Please Log In Or Join to Register for this Event.

Join Today for Instant Access to all NephU Offerings.

Membership is free!

Join NephU today at no cost to register for this event and access to other premium content.

  • The NephU Community is collaborating to improve care and the future outcomes for individuals with kidney disease and other related conditions.
  • Quickly learn more about the topics that interest you.
  • Access our library of on-demand kidney health resources
  • Gain key insights from industry experts & though leaders.